PVR

gene product
CD155, HVED, Necl-5, NECL5, PVS, Tage4
The protein encoded by this gene is a transmembrane glycoprotein belonging to the immunoglobulin superfamily. The external domain mediates cell attachment to the extracellular matrix molecule vitronectin, while its intracellular domain interacts with the dynein light chain Tctex-1/DYNLT1. The gene is specific to the primate lineage, and serves as a cellular receptor for poliovirus in the first step of poliovirus replication. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Antibodypedia Validation Initiative

Validation method

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
439 antibodies from 30 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeAVIWBELICCIPIHCFC
Invitrogen Antibodies
6 antibodies
Novus Biologicals
30 antibodies
R&D Systems
25 antibodies
Atlas Antibodies
1 antibody
GeneTex
5 antibodies
LifeSpan BioSciences, Inc.
111 antibodies
NovoPro Bioscience Inc.
7 antibodies
antibodies-online
100 antibodies
Arigo
2 antibodies
Abnova Corporation
4 antibodies
Biorbyt
19 antibodies
OriGene
3 antibodies
Aviva Systems Biology
2 antibodies
Sino Biological Inc.
22 antibodies
Bioworld Technology, Inc
1 antibody
BioLegend
19 antibodies
Boster Biological Technology
2 antibodies
Cell Signaling Technology, Inc
2 antibodies
Acris Antibodies GmbH
6 antibodies
Abgent
2 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
Creative Biolabs
6 antibodies
St John's Laboratory
3 antibodies
MyBioSource
5 antibodies
ProSci
2 antibodies
United States Biological
46 antibodies
Creative Diagnostics
4 antibodies
RayBiotech, Inc.
1 antibody
Sigma-Aldrich
1 antibody
eBioscience, An Affymetrix Company
1 antibody